Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04235101 |
Title | Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Byondis B.V. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | NLD | GBR | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University Hospital Antwerp, BE | Antwerp | 2650 | Belgium | Details | ||
Institut Jules Bordet | Brussel | 1000 | Belgium | Details | ||
Radboud University Medical Center/ NL | Nijmegen | 6500 HB | Netherlands | Details | ||
The Royal Marsden NHS Foundation Trust | London | SM2 5PT | United Kingdom | Details | ||
The Christie NHS Foundation Trust/ UK | Manchester | M20 4BX | United Kingdom | Details | ||
The Newcastle upon Tyne Hospitals NHS Foundation Trust/UK | Newcastle | NE7 7DN | United Kingdom | Details |